dChan
Anonymous ID: 312ee0 I WANDER WHAT BILL SAW THAT WAS SO AMAZING FROM A COMMUNIST COUNTRY.. April 18, 2020, 9:17 p.m. No.8847011   🗄️.is 🔗kun

A quick trip to Beijing

Breakthrough technology and other impressions from my stop in China.

By Bill Gates | June 20, 2014 3 minute read

 

 

39

Right after Melinda and I spoke at Stanford’s graduation, I took off for a quick trip to Beijing. As is often the case when I come to China, I packed a lot into two days. I left town excited about the partnerships we’re developing between the foundation and the Chinese government and enthused about technology I got to see under development.

 

One of the things I’m proudest of from my time at Microsoft is the creation and growth of Microsoft Research (MSR). Microsoft came to China very early and was one of the first multinational companies to set up a dedicated research group here. As a result, we were able to recruit amazing talent; while I’m certainly biased, I think MSR-Asia holds a nearly unique place in China and continues to attract fantastic computer scientists. I spent a couple of hours looking at work they’re doing on search linguistics, photo recognition, and data center management. All breakthrough work, and all of it potentially very important to Microsoft’s future. Not all of it will end up being included in products, but all of it was fascinating.

 

While I was there, I got to spend some time at a tech incubator program that MSR-Asia hosts for promising young Chinese entrepreneurs. Each six-month session brings in 15 to 20 startups and provides them space, mentors, technology tools, an introduction to potential sources of venture capital, and the chance to connect with potential partners. It’s a wildly popular program in China and has to turn away 25 applicants for each one accepted. After two years, 90 percent of the companies have been funded.

 

The energy was contagious and I got to see some really interesting projects dealing with everything from peer-to-peer lending to job-finding solutions for China’s enormous migrant population to 3-D rendering from normal video camera images. I was impressed with these young entrepreneurs’ desire to make a real difference for people in China.

 

In the afternoon I got the chance to sit down with Alibaba’s Jack Ma, who recently made a very generous commitment along with his business partner, Joe Tsai, to establish charitable trusts. Those commitments set a benchmark in Chinese philanthropy. Jack has long been an advocate for giving in China, so I was really pleased that he came to Beijing so we could get some time together. Jack brought together a good group of business and philanthropy leaders for dinner, and it was terrific to talk about philanthropy in China and around the world.

 

One of the government officials I met with while in town, Vice Premier Wang Yang, said something that I was struck by: “Africa today is our yesterday.” China’s ability to raise hundreds of millions of people out of poverty in the course of two generations is unprecedented in human history. And the country continues to work on raising the standard of living of its own poor. But these efforts are recent enough that China has the expertise and experience to be of tremendous assistance to places like Africa. Work with their small-holder farmers can translate into big advances for small African farmers. China’s experience with delivering basic health care across its vast territory is a remarkable resource as we look to doing the same for many African countries.

 

A great two days. I started the week with Melinda talking about the power of optimism at Stanford, and then witnessed the same here in China. And left more optimistic myself.

 

https://www.gatesnotes.com/About-Bill-Gates/Breakthrough-Tech-I-Saw-in-Beijing-China-Visit

Anonymous ID: 312ee0 OHH LOOK BILL GATES in china in NOV 2019 April 18, 2020, 9:21 p.m. No.8847040   🗄️.is 🔗kun   >>7054

Peng Liyuan, wife of Chinese President Xi Jinping and a goodwill ambassador of the World Health Organization for tuberculosis and HIV/AIDS, meets with Bill Gates, co-chair of the Bill & Melinda Gates Foundation, in Beijing, capital of China, Nov. 21, 2019. (Xinhua/Wang Ye)

BEIJING, Nov. 21 (Xinhua) – Peng Liyuan, wife of Chinese President Xi Jinping and a goodwill ambassador of the World Health Organization for tuberculosis and HIV/AIDS, met with Bill Gates, co-chair of the Bill & Melinda Gates Foundation, in Beijing Thursday.

Peng spoke highly of the effective and fruitful cooperation between the Bill & Melinda Gates Foundation and the Chinese side, hailing the progress made in the projects supported by the foundation in HIV/AIDS prevention and control and providing better healthcare for the poor people in Liangshan Yi Autonomous Prefecture in southwest China's Sichuan Province.

"China views providing better healthcare for its poor population as one of the key measures to winning the battle of poverty alleviation," Peng said.

"We hope the Bill & Melinda Gates Foundation can continue to support and participate in this field," she said.

China stands ready to continue to work with the foundation in prevention and control of tuberculosis and HIV/AIDS, and summarize and expand experience in this regard, so as to help developing countries, including those in Africa, improve their medical and healthcare levels, Peng said.

Gates hailed China's remarkable achievements in poverty reduction in the field of healthcare as well as the country's great contribution to promoting international cooperation and sustainable development.

Enhanced cooperation between the United States and China will benefit the two peoples as well as the world, he said.

The foundation is willing to further intensify its cooperation with China in the areas of healthcare, poverty reduction and public welfare, and make concerted efforts with China to help other developing countries promote agricultural and healthcare development, Gates said.

 

http://www.xinhuanet.com/english/2019-11/21/c_138573086.htm

Anonymous ID: 312ee0 April 18, 2020, 9:31 p.m. No.8847126   🗄️.is 🔗kun

so if we research the biology department at john hopkins, we have some very interesting Chinese nationals in certain molecular level fields. such as study of paralysis and exoskeleton development

Anonymous ID: 312ee0 MEET Chen-Ming Fan April 18, 2020, 9:34 p.m. No.8847155   🗄️.is 🔗kun   >>7167 >>7176 >>7193

My laboratory studies the molecular mechanisms that govern mammalian development, using the mouse as a model. We use a combination of biochemical, molecular and genetic approaches to identify and characterize signaling molecules and pathways that control the development and maintenance of the musculoskeletal and hypothalamic systems.

 

The muskuloskeletal system:

 

The musculoskeletal system provides the mechanical support for our posture and movement. How it arises during embryogenesis pertains to the basic problem of embryonic induction. How the components of this system are repaired after injury and maintained throughout life is of biological and clinical significance. We study how this system is generated and maintained.

 

The origin and induction: The musculoskeletal system of the trunk originates from a common embryonic structure called the somite. Somites are segmented mesodermal units flanking both sides of the spinal cord. Their reiterated pattern is the basis for the repeated organization of the trunk. Under the inductive influence of adjacent tissues, cells within the somite give rise to muscles and bones. We have developed a 3-dimensional culture system that allows characterization of crucial long-range and contact-dependent cellular interactions that induce early skeletal and muscle fates. Our efforts toward designing new methods and assays to track somite development have enabled us to make novel observations.

 

Induction of the axial skeletal progenitors: We have identified the Hedgehog (Hh) proteins responsible for inducing the early skeletal fate. Hh largely utilizes evolutionarily conserved downstream mediators for inductive signaling. In addition, we also found a vertebrate-specific cell surface Hh binding protein Gas1. Gas1 mutants display skeletal defects related to or due to altered Hh signaling. Mechanistically, Gas1 helps transform the Hh diffusion gradient into its observed signaling activity gradient. This unexpected mechanism provides a new vision of Hh signaling pathway initiation and has direct implications for the long-range action of Hh.

 

Induction of the early embryonic muscle: Conversely, the Wnt family of proteins plays a key role in inducing the dermis/muscle dual potential progenitors. Combining our in vitro assay with microarrays analyses, we have uncovered previously unknown effectors and target genes of Wnt. Using an ex vivo whole embryo culture system coupled with somite-specific gene delivery, we discovered an unconventional pathway for Wnt signaling via the adenylyl cyclase/protein kinase A/Creb cascade that selectively activates myogenic transcriptional determinants Myf5 and MyoD.

 

Embryonic and adult muscle stem cells: Somites not only supply cells for embryonic muscles, but also contain muscle progenitors. The proliferative capacity of these progenitors depends upon the transcription factors Pax3 and Pax7. Both genes are activated by Wnt. Using inducible cell lineage tracing, we have found that early Pax7-expressing somitic cells directly give rise to adult muscle stem cells, i.e. the satellite cells. Lineage tracing of Pax7-expressing adult satellite cells indicates that they are indeed a stem cell source for muscle regeneration. Conditional inactivation of Pax7 at different developmental time points reveals that Pax7 is required for the proliferative properties of muscle progenitors up to 3 weeks after birth when they transition into quiescence. After this transition is made, however, both Pax3 and Pax7 are completely dispensable. Our finding of an age-dependent cell-intrinsic change in the genetic requirement for muscle stem cells cautions against inferring adult stem cell biology from embryonic studies, and has direct implications for the use of stem cells from hosts of different ages in transplantation-based therapies.